• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替米沙坦通过改变血管紧张素-(1-7)mas 受体表达及其 PPAR-γ 激动剂作用减轻链脲佐菌素诱导的糖尿病小鼠氧化应激和肾纤维化。

Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.

机构信息

Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata City, Japan.

出版信息

Free Radic Res. 2011 May;45(5):575-84. doi: 10.3109/10715762.2011.560149. Epub 2011 Mar 7.

DOI:10.3109/10715762.2011.560149
PMID:21381899
Abstract

The beneficial effects of telmisartan on Angiotensin (Ang)-II mediated oxidative stress and renal fibrosis in streptozotocin (STZ)-induced diabetic nephropathy (DN) were studied. Thirty mice were divided into normal (NG), STZ-induced diabetic (DG) and telmisartan-treated diabetic (TG) groups. Compared with NG mice, DG mice showed significant up-regulations of AT-1R, TGF-β1, p-p38MAPK, p-MAPKAPK-2, p-Akt, p47phox, p67phox, gp91phox protein and collagen-III and all of these were significantly reversed in TG mice. The down-regulated protein expression of Ang-(1-7) mas receptor, ACE-2, PPAR-γ and PGC-1α were observed in DG mice and a significant up-regulation effect of telmisartan has been seen in the TG mice. Furthermore, TG mice showed reduced expression of fibronectin, production of superoxide radical as well as renal hypertrophy and fibrosis when compared with DG mice. These findings suggest that Ang-II plays a significant role in DN and telmisartan would be beneficial in reducing oxidative stress and fibrosis in STZ-induced DN.

摘要

研究了替米沙坦对链脲佐菌素(STZ)诱导的糖尿病肾病(DN)中血管紧张素(Ang)-II 介导的氧化应激和肾纤维化的有益作用。将 30 只小鼠分为正常(NG)、STZ 诱导的糖尿病(DG)和替米沙坦治疗的糖尿病(TG)组。与 NG 组相比,DG 组 AT-1R、TGF-β1、p-p38MAPK、p-MAPKAPK-2、p-Akt、p47phox、p67phox、gp91phox 蛋白和胶原-III 的表达明显上调,而这些在 TG 组均明显逆转。DG 组 Ang-(1-7)mas 受体、ACE-2、PPAR-γ 和 PGC-1α 的蛋白表达下调,替米沙坦有明显的上调作用。此外,与 DG 组相比,TG 组的纤维连接蛋白表达减少,超氧自由基生成减少,肾肥大和纤维化减轻。这些发现表明 Ang-II 在 DN 中起重要作用,替米沙坦有益于减轻 STZ 诱导的 DN 中的氧化应激和纤维化。

相似文献

1
Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.替米沙坦通过改变血管紧张素-(1-7)mas 受体表达及其 PPAR-γ 激动剂作用减轻链脲佐菌素诱导的糖尿病小鼠氧化应激和肾纤维化。
Free Radic Res. 2011 May;45(5):575-84. doi: 10.3109/10715762.2011.560149. Epub 2011 Mar 7.
2
Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.奥美沙坦通过调控 AT-1R/MAPK 级联反应减轻链脲佐菌素诱导的糖尿病小鼠的糖尿病肾病。
Mol Cell Endocrinol. 2012 Jan 2;348(1):104-11. doi: 10.1016/j.mce.2011.07.041. Epub 2011 Jul 30.
3
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.替米沙坦通过PPAR-γ-eNOS途径对盐敏感型高血压大鼠的心脏保护机制
Am J Hypertens. 2008 May;21(5):576-81. doi: 10.1038/ajh.2008.27. Epub 2008 Mar 20.
4
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.替米沙坦通过改变与 PPAR-γ 激动剂作用相关的血管紧张素 II 和内皮素-1 受体表达来预防柔红霉素大鼠的肾损伤进展。
Toxicology. 2011 Jan 11;279(1-3):91-9. doi: 10.1016/j.tox.2010.09.013. Epub 2010 Oct 1.
5
Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.替米沙坦通过调节 ACE-2/ANG 1-7/mas 受体在实验性自身免疫性心肌炎诱导的扩张型心肌病大鼠中发挥作用。
Life Sci. 2012 Feb 13;90(7-8):289-300. doi: 10.1016/j.lfs.2011.11.018. Epub 2011 Dec 19.
6
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.替米沙坦通过过氧化物酶体增殖物激活受体-γ/肝细胞生长因子途径发挥肾保护作用,不依赖血管紧张素 II 型 1 受体阻断。
Hypertension. 2012 Feb;59(2):308-16. doi: 10.1161/HYPERTENSIONAHA.111.176263. Epub 2012 Jan 17.
7
Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.与α-硫辛酸相比,黄葵胶囊通过调节氧化应激和p38丝裂原活化蛋白激酶/蛋白激酶B(p38MAPK/Akt)信号通路减轻糖尿病肾病大鼠的肾纤维化。
J Ethnopharmacol. 2015 Sep 15;173:256-65. doi: 10.1016/j.jep.2015.07.036. Epub 2015 Jul 28.
8
AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.替米沙坦阻断 AT1 受体可上调糖尿病大鼠体内的 GTP 环化水解酶 I 并保护内皮型一氧化氮合酶。
Free Radic Biol Med. 2008 Sep 1;45(5):619-26. doi: 10.1016/j.freeradbiomed.2008.05.009. Epub 2008 May 23.
9
Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: studies on possible molecular mechanisms.替米沙坦改善 STZ 诱导的糖尿病大鼠生殖细胞毒性:可能的分子机制研究。
Mutat Res. 2013 Jul 4;755(1):11-23. doi: 10.1016/j.mrgentox.2013.04.013. Epub 2013 May 3.
10
Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.血管紧张素转换酶抑制和血管紧张素 AT1 受体阻断下调链脲佐菌素诱导的糖尿病大鼠血管紧张素转换酶表达并减轻肾脏损伤。
J Biochem Mol Toxicol. 2013 Jul;27(7):378-87. doi: 10.1002/jbt.21500. Epub 2013 Jun 3.

引用本文的文献

1
PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms.PGC1-α 在糖尿病肾病中的作用:揭示其肾脏保护作用及分子机制。
Mol Biol Rep. 2024 Feb 15;51(1):304. doi: 10.1007/s11033-024-09232-y.
2
Sex Difference in MasR Expression and Functions in the Renal System.性别差异在肾脏系统中的 MasR 表达和功能。
J Renin Angiotensin Aldosterone Syst. 2022 Sep 10;2022:1327839. doi: 10.1155/2022/1327839. eCollection 2022.
3
Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.
坎地沙坦通过影响 Nrf2、NF-κB、Bax/Bcl-2/Cyt-C 和 Ang II/Ang 1-7 信号来预防镉诱导的肝肾综合征。
Biol Trace Elem Res. 2023 Apr;201(4):1846-1863. doi: 10.1007/s12011-022-03286-4. Epub 2022 May 19.
4
Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy.血管紧张素转换酶2的激活:糖尿病肾病的一种新治疗策略。
Front Physiol. 2022 Jan 11;12:813012. doi: 10.3389/fphys.2021.813012. eCollection 2021.
5
Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.肾素-血管紧张素系统抑制剂对血管紧张素转换酶 2 的过表达作用:事实还是虚构?一项动物研究的系统综述。
Hypertens Res. 2021 Aug;44(8):955-968. doi: 10.1038/s41440-021-00641-1. Epub 2021 Mar 10.
6
Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!肾素-血管紧张素-醛固酮系统调节在糖尿病肾病中的潜力:旧有靶点带来新希望!
Rev Physiol Biochem Pharmacol. 2021;179:31-71. doi: 10.1007/112_2020_50.
7
Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts.使用 Tel 和多西紫杉醇脂质体联合靶向肺癌干细胞在 3D 培养物和肿瘤异种移植物中。
Toxicol Appl Pharmacol. 2020 Aug 15;401:115112. doi: 10.1016/j.taap.2020.115112. Epub 2020 Jun 12.
8
Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.血管紧张素 II 型 1 型受体阻滞剂可改善糖尿病肾病患者肾脏血管紧张素 II 和 MAS 受体的表达。
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320919607. doi: 10.1177/1470320320919607.
9
Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR- Activation and Subsequent Regulation of TGF-1 and HGF Expression.罗格列酮通过促进 PPAR 激活及随后对 TGF-β1 和 HGF 表达的调节,抑制草酸钙晶体结合和草酸诱导的肾小管上皮细胞氧化应激。
Oxid Med Cell Longev. 2019 Nov 12;2019:4826525. doi: 10.1155/2019/4826525. eCollection 2019.
10
Role of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review.转化生长因子-β在骨骼肌纤维化中的作用:综述。
Int J Mol Sci. 2019 May 17;20(10):2446. doi: 10.3390/ijms20102446.